Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer

BACKGROUND: Adjuvant chemotherapy (ACT) can improve prognosis for stages II-IIIA patients with non-small-cell lung cancer (NSCLC), but its implication in stage I patients is still an intractable puzzle. This study aims to seek ACT candidates for stage IB NSCLC and establish a nomogram to predict ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Zegui, Tian, Tian, Chen, Qian, Li, Caili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313364/
https://www.ncbi.nlm.nih.gov/pubmed/34335761
http://dx.doi.org/10.1155/2021/8052752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313364/
https://www.ncbi.nlm.nih.gov/pubmed/34335761
http://dx.doi.org/10.1155/2021/8052752

Ejemplares similares